The MyMeds&Me team includes experts from the fields of pharmacovigilance, clinical development coupled to software development and implementation. Our experts will share their thoughts and expertise through the MyMeds&Me blog. Planned topics include modernising pharmacovigilance, practical impacts of transforming your drug safety operations and real-world technology implementation advice. Please feel free to comment on the blog posts and to suggest future topics or ask questions.

Thank you for reading!

11 January 2016

Making the Transition from Passive to Active Pharmacovigilance

In preparation for my presentation at Pharmadanmark, I have been documenting the growing pressures on life sciences and the rapidly developing Pharmacovigilance landscape. I believe there is an imperative need to move from manual to automated PV processes to respond to these changes and to deliver higher levels of compliance & improved quality.
By Dr Andrew Rut
31 March 2015

Debating the Future of Spontaneous Reporting

At first glance, receiving an invitation to mark an important MHRA milestone with esteemed industry colleagues in Edinburgh sounded like an excellent opportunity to catch up with pharmacovigilance and regulatory colleagues. Edinburgh is just a short flight from London and the city is steeped in history, culture and science. How could I say no?
By Dr Andrew Rut
  • 1

We’re going to hear from @GSK's Danie Du Plessis at this #DIAeuro17 talk on patient-centric #clinicaltrials research

Have we future-proofed #pharmacovigilance research? We’re fascinated to see this #DIAeuro17 panel (tomorrow 16:30)

Our Reportum #drugsafety solution saves pharma co's time by working with your system. Join us - #DIAeuro17 booth F12

Keep informed

For expert insight and updates from the MyMeds&Me team.

We respect your privacy and we will only use your email address for newsletters and company updates